Phenytoin adverse effects
What it is
Phenytoin is a second line drug for status epilepticus, which is continuous seizure activity for more than 5-10 min, or 2 or more seizures without full recovery. First line is a benzodiazepine, lorazepam or diazepam or midazolam, and if the first dose does not work a second dose of the first line is given before moving on. If seizures continue, second line is phenytoin 20 mg/kg or fosphenytoin 20 mg/kg, with valproate, levetiracetam and lacosamide as the other drugs of this step, and phenobarbital 20 mg/kg either here or as the step just after it. If seizures still continue, third line is general anesthesia with propofol, midazolam, pentobarbital or ketamine. The rate matters as much as the dose: phenytoin has a max infusion of 50 mg/min, while fosphenytoin has a higher max, 150 mg/min, also written 150 PE/min for a dose written as 20 PE/kg. The bloods sent in the first minutes of status epilepticus include AED levels, along with CMP, CBC, ABG, alcohol and a toxicology screen.
What can go wrong
Two harms are named for phenytoin.
- Gingival hyperplasia. Phenytoin is on the list of its causes, along with ciclosporin, CCBs such as nifedipine, and AML.
- Harm to the fetus. Phenytoin is on the list of drugs not to be given during pregnancy, where the harm named is fetal hydantoin syndrome, described as craniofacial changes and growth retardation. Warfarin, tetracycline and ACEi sit on that same list. Mothers with epilepsy also have a 2-3 fold increased risk of fetal anomalies.
Other than those two the drug carries a longer list of its own, and the uses it is given for are GTC seizures and status epilepticus after benzos. The named side effects are gingival hyperplasia, hirsutism, acne, ataxia and nystagmus, with the drug marked a teratogen for fetal hydantoin, and zero-order kinetics.
Phenytoin also appears in the maternal drug history taken when a child is evaluated for congenital heart disease: the anomalies named for it there are VSD and ASD. It sits on that list beside maternal rubella with PDA, maternal diabetes with transposition of great vessels, maternal thyroid disease with heart failure, maternal lithium use during pregnancy with Ebstein's anomaly, and fetal alcohol syndrome with VSD and ASD.